Loading data
MXCTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.96 m USD | 22.22 m USD | 19.5 m USD | 28.75 m USD | 21.57 m USD |
| Cost of revenue | 6.22 m USD | 7.1 m USD | 4.74 m USD | 5.1 m USD | 3.65 m USD |
| Gross profit | 26.8 m USD | 31.53 m USD | 36.55 m USD | 39.16 m USD | 30.25 m USD |
| Research and development expense | 20.82 m USD | 22.23 m USD | 23.82 m USD | 19.51 m USD | 15.41 m USD |
| Operating profit | -51.9 m USD | -51.2 m USD | -48.3 m USD | -27.36 m USD | -18.19 m USD |
| Interest expense | — | — | — | — | 5.4 k USD |
| Profit before tax | -44.63 m USD | -41.06 m USD | -37.92 m USD | — | — |
| Income tax expense | — | — | — | — | 0 USD |
| Net income (reported basis) | -44.63 m USD | -41.06 m USD | -37.92 m USD | -23.57 m USD | -19.08 m USD |
| Basic earnings per share | -0.42 USD/share | -0.39 USD/share | -0.37 USD/share | -0.23 USD/share | -0.21 USD/share |
| Diluted earnings per share | -0.42 USD/share | -0.39 USD/share | -0.37 USD/share | -0.23 USD/share | -0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.